D115 Unit 5: Hypertension and Cardiovascular Conditions Review
Student Name
Western Governors University
D115 Advanced Pathophysiology for the Advanced Practice Nurse
Prof. Name
Date
Hypertension
What is Hypertension?
Hypertension refers to a chronic condition where the systemic arterial blood pressure remains elevated persistently. Traditionally, hypertension was defined by systolic blood pressure readings of 140 mmHg or higher, or diastolic readings of 90 mmHg or higher, based on the 2014 clinical guidelines. However, newer evidence prompted a revision in 2017, lowering these diagnostic thresholds to systolic blood pressure of 130 mmHg or more and diastolic pressure of 80 mmHg or above. This change acknowledges the increased cardiovascular risk associated with even moderately elevated blood pressure levels (American College of Cardiology/American Heart Association Task Force, 2017; James et al., 2014).
What is the Epidemiology of Hypertension?
Hypertension is the most common primary diagnosis in the United States and affects a large portion of the adult population. Approximately 95% of hypertension cases are categorized as primary or essential hypertension, where no identifiable cause is found. The remaining 5% are cases of secondary hypertension, which result from specific medical conditions such as chronic kidney disease or endocrine disorders. This distinction is important because secondary hypertension can often be treated by addressing the underlying cause (Mayo Clinic, 2025).
What Types of Hypertension Exist?
| Type | Characteristics | Cause | Outcome |
|---|---|---|---|
| Primary (Essential) | No specific identifiable cause; multifactorial | Combination of genetic predisposition and environmental factors | Leads to sustained elevation in vascular tone and blood volume, causing persistent hypertension |
| Secondary | Result of identifiable underlying disease | Often due to renal or endocrine abnormalities causing increased peripheral resistance or cardiac output | Potentially reversible if the underlying condition is treated early |
Primary hypertension accounts for the majority of cases and develops due to complex interactions between inherited traits and lifestyle factors. In contrast, secondary hypertension is linked to specific, often treatable conditions (American College of Cardiology/American Heart Association Task Force, 2017).
What Are the Risk Factors for Primary Hypertension?
Risk factors contributing to primary hypertension can be grouped into three categories:
Nonmodifiable: Includes increasing age, genetic predisposition, ethnicity, and family history.
Socioeconomic and Behavioral: Factors such as low educational attainment, socioeconomic challenges, tobacco use, psychological stress, and obstructive sleep apnea.
Dietary and Metabolic: High sodium and fat intake, obesity, and impaired glucose metabolism.
These risk factors also play a significant role in the development of cardiovascular diseases, emphasizing the need for early lifestyle interventions (James et al., 2014).
What is the Pathophysiology of Hypertension?
The underlying mechanism of hypertension involves either an increase in cardiac output, an increase in total peripheral vascular resistance, or a combination of both. Prolonged elevated blood pressure can lead to progressive damage to critical organs including the heart, kidneys, brain, and blood vessels (American College of Cardiology/American Heart Association Task Force, 2017).
What are the Clinical Manifestations of Hypertension?
Often termed the “silent killer,” hypertension may initially present without symptoms. When organ damage occurs, clinical signs such as coronary artery disease, heart failure, renal impairment, stroke, cognitive decline, vision problems, peripheral edema, or vascular occlusion might develop (Mayo Clinic, 2025).
How is Hypertension Diagnosed?
Accurate diagnosis requires multiple blood pressure measurements on at least two separate visits. Each visit should include at least two readings spaced by two minutes. Measurements must follow strict protocols: patients should be seated comfortably with their arm supported at heart level, rested for at least five minutes, and abstain from caffeine, exercise, or smoking beforehand (James et al., 2014).
How is Hypertension Managed?
Management strategies focus on both non-pharmacologic and pharmacologic approaches. Lifestyle modifications such as dietary changes (e.g., DASH diet), regular physical activity, weight loss, stress management, and tobacco cessation are foundational. Drug therapy is introduced based on blood pressure severity and patient-specific risk factors, following contemporary guidelines (American College of Cardiology/American Heart Association Task Force, 2017).
Metabolic Syndrome
What is Metabolic Syndrome?
Metabolic syndrome is a cluster of interconnected metabolic abnormalities that significantly increase the risk for type 2 diabetes mellitus and cardiovascular disease. It reflects an underlying pathophysiologic process involving insulin resistance, central adiposity, and lipid abnormalities (National Heart, Lung, and Blood Institute, 2025).
What are the Components of Metabolic Syndrome?
| Component | Description |
|---|---|
| Central (abdominal) obesity | Excess fat accumulation around the abdomen |
| Dyslipidemia | Abnormal lipid levels, including elevated triglycerides and low HDL cholesterol |
| Prehypertension | Elevated blood pressure that is not yet in the hypertensive range |
| Elevated fasting blood glucose | Higher than normal blood sugar levels indicating insulin resistance |
These components collectively increase cardiovascular risk beyond the sum of individual factors (National Heart, Lung, and Blood Institute, 2025).
What is the Epidemiology of Metabolic Syndrome?
Metabolic syndrome can develop early in life and is increasingly prevalent among sedentary adults and overweight children and adolescents. This early onset highlights the critical importance of prompt identification and intervention to prevent progression to diabetes and cardiovascular events (National Heart, Lung, and Blood Institute, 2025).
How is Metabolic Syndrome Managed?
Management prioritizes early screening and aggressive lifestyle interventions aimed at weight reduction, nutritional optimization, and enhancing physical activity. Such measures can mitigate risks and improve long-term outcomes (National Heart, Lung, and Blood Institute, 2025).
Deep Vein Thrombosis (DVT)
What is Deep Vein Thrombosis?
Deep vein thrombosis is a condition where a blood clot forms in the deep veins, most commonly in the lower extremities. The thrombus remains attached to the vein wall, posing a risk for embolization (Kahn et al., 2024).
What are the Risk Factors for DVT?
| Risk Factor |
|---|
| Hospitalization |
| Trauma |
| Orthopedic surgery |
| Age over 60 |
| Pregnancy |
| Malignancy |
| Inherited thrombophilias (e.g., Factor V Leiden mutation) |
These factors contribute to the development of venous thromboembolism through mechanisms such as immobilization, vascular injury, or hypercoagulability (Kahn et al., 2024).
What is the Pathophysiology of DVT?
DVT arises due to the interplay of Virchow’s triad: venous stasis, endothelial damage, and a hypercoagulable state. These conditions favor clot formation, particularly near venous valves where blood flow is slower (Kahn et al., 2024).
What are the Clinical Manifestations of DVT?
Patients with DVT may be asymptomatic or exhibit signs such as unilateral limb pain, swelling, dilated superficial veins, and skin discoloration. Early recognition is vital to prevent complications (Kahn et al., 2024).
How is DVT Diagnosed?
Initial screening often involves a D-dimer blood test, which is highly sensitive but not specific. Confirmation is typically achieved through compression Doppler ultrasound, the diagnostic standard (Kahn et al., 2024).
What are the Prevention and Treatment Strategies for DVT?
Prevention includes early mobilization after surgery or hospitalization and the use of mechanical devices like compression stockings. Treatment primarily involves anticoagulation therapy tailored to patient risk and clinical scenario (Kahn et al., 2024).
Angina Pectoris
What is Angina Pectoris?
Angina pectoris is chest discomfort or pain caused by myocardial ischemia due to reduced blood flow in coronary arteries.
What Types of Angina Exist?
| Type | Description | Clinical Features | Treatment |
|---|---|---|---|
| Stable Angina | Predictable pain with exertion | Relieved by rest; no myocardial necrosis | Lifestyle changes, nitrates |
| Unstable Angina | Occurs unpredictably, often at rest or increasing frequency | Associated with plaque rupture; high risk of myocardial infarction | Requires urgent medical intervention |
| Prinzmetal (Variant) Angina | Caused by coronary artery spasm | Occurs at rest, frequently nocturnal | Calcium channel blockers, nitrates |
Each angina type has distinct pathophysiology and clinical management approaches (Mayo Clinic, 2025).
Heart Failure
What is Heart Failure?
Heart failure occurs when the heart cannot pump sufficient blood to meet the body’s needs or maintain adequate filling pressures.
What are the Types of Heart Failure?
| Type | Features |
|---|---|
| Left-sided Systolic (HFrEF) | Reduced ejection fraction (<40%), impaired contractility |
| Left-sided Diastolic (HFpEF) | Preserved ejection fraction, impaired relaxation |
| Right-sided Heart Failure | Usually secondary to left-sided failure; leads to systemic venous congestion |
Understanding the type of heart failure guides therapeutic decisions (Mayo Clinic, 2025).
Cardiogenic Shock
What is Cardiogenic Shock?
Cardiogenic shock is a life-threatening state in which the heart fails to pump sufficient blood despite adequate filling pressures, resulting in hypotension and inadequate tissue perfusion.
What are the Clinical Features of Cardiogenic Shock?
Clinical manifestations include low blood pressure, rapid heartbeat, difficulty breathing, and signs of organ dysfunction or failure due to hypoperfusion (Mayo Clinic, 2025).
Hypoplastic Left Heart Syndrome (HLHS)
What is HLHS?
HLHS is a severe congenital defect characterized by underdevelopment of the left heart structures, which impairs systemic blood flow.
How Does HLHS Present?
Newborns with HLHS may appear normal initially but rapidly deteriorate when the ductus arteriosus closes, leading to critical circulatory failure.
How is HLHS Managed?
Management includes continuous prostaglandin infusion to maintain ductal patency and a series of staged surgeries (Norwood, Glenn, Fontan) to palliate the defect (Mayo Clinic, 2025).
Hematologic Disorders
What are Some Key Hematologic Disorders?
| Disorder | Description | Key Features |
|---|---|---|
| Sickle Cell Disease | Autosomal recessive disorder causing abnormal hemoglobin | Chronic vaso-occlusion and hemolysis leading to organ damage |
| Disseminated Intravascular Coagulation (DIC) | Systemic activation of coagulation and fibrinolysis | Simultaneous bleeding and thrombosis |
| Pernicious Anemia | Vitamin B12 deficiency due to intrinsic factor loss | Megaloblastic anemia with neurologic symptoms |
| Iron Deficiency Anemia | Most common anemia worldwide due to blood loss or poor intake | Microcytic, hypochromic RBCs |
What Are Leukemias?
| Type | Characteristics | Common Demographics |
|---|---|---|
| Acute Leukemias | Rapid proliferation of immature blasts | ALL common in children; AML in adults |
| Chronic Leukemias | Involvement of more mature cells | CLL marked by smudge cells and immune dysfunction |
Myocardial Infarction
What is a Myocardial Infarction?
A myocardial infarction (MI) results from prolonged ischemia causing irreversible myocardial cell death.
What are the Types of MI?
| Type | Description |
|---|---|
| STEMI | Transmural infarction involving full thickness of myocardium |
| NSTEMI | Subendocardial infarction affecting inner myocardial layers |
How is MI Diagnosed?
Diagnosis is confirmed by elevated cardiac biomarkers, especially troponins, and characteristic electrocardiographic (ECG) changes (American College of Cardiology/American Heart Association Task Force, 2017).
What is the Management of MI?
Treatment includes prompt reperfusion via percutaneous coronary intervention (PCI) or thrombolytics. Antiplatelet and anticoagulant medications are standard, along with long-term management to modify cardiovascular risk factors (American College of Cardiology/American Heart Association Task Force, 2017).
Neurologic Disorders
What are Important Concepts in Neurologic Disorders?
Cerebral perfusion pressure (CPP) is calculated as mean arterial pressure (MAP) minus intracranial pressure (ICP). Elevated ICP reduces cerebral blood flow, potentially causing brain injury. Damage to the brainstem affects consciousness and autonomic vital functions (Mayo Clinic, 2025).
What Are Major Neurologic Conditions?
Key neurologic disorders include locked-in syndrome, subarachnoid hemorrhage, spinal cord injury complicated by autonomic dysreflexia, cerebral edema with herniation, seizures, epilepsy, delirium, and dementia.
References
American College of Cardiology/American Heart Association Task Force. (2017). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Journal of the American College of Cardiology, 71(19), e127-e248.
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., … & Ortiz, E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults. JAMA, 311(5), 507-520.
Kahn, S. R., et al. (2024). Deep vein thrombosis and pulmonary embolism. The Lancet, 393(10172), 1839-1852.
Mayo Clinic. (2025). Hypertension (high blood pressure). https://www.mayoclinic.org/diseases-conditions/high-blood-pressure
National Heart, Lung, and Blood Institute. (2025). What is metabolic syndrome? https://www.nhlbi.nih.gov/health-topics/metabolic-syndrome
Get WGU Free MSN Samples
D024
- D024 SEI Skill Sets Discussion – Self-Awareness & Management Insights
- D024 Phase 1 Video Reflection
- D024 CPE Schedule and SEI Reflection Report
- D024 FAQ: Submission and CPE Record Guidance
- D024 Phase 1 Reflection on Leadership and Growth Strategies
- D024 Joy in the Workplace: Force Field Analysis Summary
- D024 Professional Presence & Influence: CPE Record Template Task 1
D025
- D025 Phase 2 Reflection: Insights on Team Leadership and Advocacy
- D025: Phase 1 Reflection on Health Policy Advocacy Insights
- D025 Task 1: Clinical Practice Experience
- D025 Task 1 ISBAR Summary
- D025 Final Exam: Advocacy for Policy Change in Community Health
- D025 Task 2 Advocating for Policy Change to Improve Health Outcomes in the Community
D026
D027
- D027 Alzheimer’s Disease (AD) Final Synthesis: Understanding Key Aspects
- D027 OA Final Exam Study Guide: Key Concepts and Conditions
- D027 Shadow Health Treatment Plan for Dr. Douglas: Phase 3 Guide
- D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries
- D027 – Comprehensive Study Guide for Health Disorders and Treatments
- D027 E-Portfolio: Advanced Pathopharmacological Foundations
- D027 Study Guide – Advanced Pathopharmacology Notes
D028
D029
- D029 Narrative Essay: Innovations in Nursing Informatics
- D029 CPE Phase 2
- D029 Emerging Tech Annotated Bibliography for Nursing Care
- D029 Annotated Bibliography
- D029 Population Health Data Paper
- D029 Task 1 E-Portfolio: Clinical Practice Experience Analysis
- D029 Task 1: Analyzing Population Health Data in Strafford Country
D030
D031